| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $25.10M | $26.64M | $29.63M | $30.64M | $22.97M |
| R&D | $15.89M | $17.73M | $19.49M | $18.97M | $14.42M |
| SG&A | $9.12M | $8.79M | $10.02M | $11.54M | $8.39M |
| Operating Income | -$25.10M | -$26.64M | -$29.63M | -$30.64M | -$22.97M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$33.56M | -$21.76M | -$29.77M | -$29.02M | -$15.89M |
| EPS (basic) | -28.4200 | -6.3200 | -15.0700 | -1.0100 | -0.5900 |
| EPS (diluted) | – | – | – | – | – |
| Shares (diluted) | – | – | – | – | – |